Generation and Initial Characterization of FDD Knock In Mice
Open Access
- 18 November 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (11) , e7900
Abstract
Mutations in the integral membrane protein 2B [1], also known as BRI2 [2], a type II trans-membrane domain protein cause two autosomal dominant neurodegenerative diseases, Familial British and Danish Dementia [3]. In these conditions, accumulation of a C-terminal peptide (ABri and ADan) cleaved off from the mutated precursor protein by the pro-protein convertase furin [4], leads to amyloid deposition in the walls of blood vessels and parenchyma of the brain. Recent advances in the understanding of the generation of amyloid in Alzheimer's disease has lead to the finding that BRI2 interacts with the Amyloid Precursor Protein (APP), decreasing the efficiency of APP processing to generate Aβ [5], [6], [7]. The interaction between the two precursors, APP and BRI2, and possibly between Aβ and ABri or ADan, could be important in influencing the rate of amyloid production or the tendency of these peptides to aggregate. We have generated the first BRI2 Danish Knock-In (FDDKI) murine model of FDD, expressing the pathogenic decamer duplication in exon 6 of the BRI2 gene. FDDKI mice do not show any evident abnormal phenotype, with normal brain histology and no detectable amyloid deposition in blood vessel walls or parenchyma. This new murine mouse model will be important to further understand the interaction between APP and BRI2, and to provide insights into the molecular basis of FDD.Keywords
This publication has 32 references indexed in Scilit:
- BRI3 Inhibits Amyloid Precursor Protein Processing in a Mechanistically Distinct Manner from Its Homologue Dementia Gene BRI2Journal of Biological Chemistry, 2009
- Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional roleMolecular Neurodegeneration, 2008
- The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanismProceedings of the National Academy of Sciences, 2007
- Modeling Familial British Dementia in Transgenic MiceBrain Pathology, 2006
- Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brainActa Neuropathologica, 2003
- Regional Distribution of Amyloid-Bri Deposition and Its Association with Neurofibrillary Degeneration in Familial British DementiaThe American Journal of Pathology, 2001
- The Value of Transgenic Models for the Study of Neurodegenerative DiseasesAnnals of the New York Academy of Sciences, 2000
- A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindredProceedings of the National Academy of Sciences, 2000
- Mice cloned from embryonic stem cellsProceedings of the National Academy of Sciences, 1999
- Isolation of Markers for Chondro-osteogenic Differentiation Using cDNA Library SubtractionJournal of Biological Chemistry, 1996